MeiraGTx Corp (MGTX) - Bozor kapitallashuvining balans qiymatiga nisbati
MeiraGTx Holdings plc (MGTX) xavfsiz geosiyosiy muhitda faoliyat yuritib, savdo cheklovlarisiz global tadqiqotlar olib bormoqda. Biznes genetik tibbiyotdagi eksklyuziv patentlarga tayanadi, bu esa monopoliya sharoitlarini va barqaror naqd pul oqimini yaratadi. Narxlarning ushbu harakati 4.18 darajasida mustahkamlangan bozor dinamikasini aks ettiradi. Shu bilan birga, kompaniya bioetik prinsiplarga qat'iy rioya qiladi va chiqindilarni yo'q qilish jarayonida atrof-muhitga ta'sirni minimallashtiradi.
%20Kapitallashuvning%20balans%20qiymatiga%20nisbati&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_MGTX_-_MeiraGTx-Holdings-plc_-_Capitalization-to-Book-Value-Ratio "MGTX: meiragtx.com Bozor qiymatining balans qiymatiga nisbati 04.07.2022 - 31.10.2026 | 👁️GURU.Markets👁️")
MeiraGTx Holdings (MGTX) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning xususiy kapitalga nisbati MeiraGTx Holdings plc|MGTX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati MeiraGTx PLC|MGTX - Kompaniyaning umumiy yig'indi qarzi|Balans kapitallashuviga qarzlar MeiraGTx PLC|MGTX - Uzoq muddatli qarz hajmi|Kompaniyaning qisqa muddatli qarzi MeiraGTx|Tezkor likvidlik koeffitsiyenti meiragtx.com
- foyda va bozor multiplikatorlari tafsilotlari:
Kompaniyaning har tomonlama tahlili:MeiraGTx Holdings plc - MGTX
Ushbu grafik MeiraGTx Holdings plc (MGTX) bozor narxi va uning sof aktivlari qiymati o'rtasidagi farqni aks ettirib, bozor gen terapiyasi sohasidagi kelgusidagi muvaffaqiyatlar uchun to'lashga tayyor bo'lgan premiumni o'lchaydi. Buxgalteriya qiymatiga nisbatan narx koeffitsiyentini tahlil qilish orqali investor moddiy resurslarga nisbatan baholash premiumining miqdorini ko'rishi mumkin, bu esa yuqori kapital sarfi va klinik muvaffaqiyatsizliklar bilan birgalikda investitsiyalarning butunlay yo'qolishi xavfini kritik darajada oshiradi.
MeiraGTx Holdings plc (MGTX) raqobatchilari
TEM (Tempus Labs) - Kapitallashuvning sof aktivlarga nisbati|Kapitallashuvning balans qiymatiga nisbati QGEN|IONS (Ionis) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati RGEN (Repligen Corp)|Bozor qiymatining balans qiymatiga nisbati Avidity (RNA)|CRISPR - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati WGS (GeneDx Holdings Corp.)|Bozor kapitallashuvining balans qiymatiga nisbati ultragenyx.com RARE|BEAM - Bozor qiymatining balans qiymatiga nisbati|Sarepta Therapeutics (SRPT) - Kapitallashuvning sof aktivlarga nisbati|TWST: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti 10x (TXG)|NTLA (Intellia Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|stoketherapeutics.com (STOK) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati BioLife Solutions (BLFS)|WVE (Wave Life Sciences Ltd) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati MAZE (Maze Tx)|Bozor kapitallashuvining balans qiymatiga nisbati Sionna Corp SION|Prime Medicine, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining xususiy kapitalga nisbati tayshagtx.com (TSHA)|QURE (uniQure) - Kapitallashuvning sof aktivlarga nisbati|RGNX: Bozor kapitallashuvining balans qiymatiga multiplikatori|Kapitallashuvning sof aktivlarga nisbati SLDB|Kapitallashuvning balans qiymatiga nisbati OCGN (Ocugen Pharma)|Kapitallashuvning sof aktivlarga nisbati PACB (Pacific Biosciences)|BNTC (benitec.com) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati DSGN (Design Therapeutics, Inc.)|Balans qiymatiga nisbatan bozor qiymati RCKT|FDMT - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Lexeo Therapeutics|korrobio.com (KRRO) - Bozor qiymatining balans qiymatiga nisbati|EDIT (editasmedicine.com) - Bozor qiymatining balans qiymatiga nisbati|SLN (Silence Therapeutics plc) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati PRQR (ProQR Therapeutics NV)|Bozor kapitallashuvining balans qiymatiga nisbati CDXS|Balans qiymatiga nisbatan bozor kapitallashuvi Sangamo BioSciences|Bozor qiymatining balans qiymatiga nisbati Nautilus Bio NAUT|MGX: Kapitallashuvning balans qiymatiga nisbati|Precision BioSciences - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining xususiy kapitalga nisbati Generation Bio Co. (GBIO)|Boundless Bio, Inc (BOLD) - Bozor qiymatining balans qiymatiga nisbati|XCUR - Balans qiymatiga nisbatan bozor kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati IMNN|PHIO: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Mustang Bio, Inc. (MBIO)|RNAZ: Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Bionano Genomics BNGO|Applied DNA Corp - Bozor qiymatining balans qiymatiga nisbati|bluebird bio, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|ImmunoPrecise Antibodies (IPA) - Kapitallashuvning sof aktivlarga nisbati|Omega Therapeutics, Inc. (OMGA) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Singular Genomics Systems, Inc.|RGLS (Regulus Therapeutics Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|SYRS - Bozor qiymatining xususiy kapitalga nisbati|Kapitallashuvning sof aktivlarga nisbati TBIO (Telesis Bio, Inc.)|Bozor kapitallashuvining balans qiymatiga multiplikatori TCON|Unity Biotechnology, Inc. - Kapitallashuvning sof aktivlarga nisbati